Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.10.0.1
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported in the Consolidated Balance Sheets to the total of the amounts in the Consolidated Statements of Cash Flows as of September 30, 2018, December 31, 2017, September 30, 2017 and December 31, 2016.

 

(Dollars in thousands)   September 30, 2018     December 31,
2017 		    September 30, 2017     December 31,
2016 		 
Cash and cash equivalents   $ 6,632     $ 7,307     $ 9,001     $ 4,105  
                                 
Restricted cash included in current/long term assets     636       691       691       692  
                                 
Cash, cash equivalents and restricted cash in the statement of cash flows   $ 7,268     $ 7,998     $ 9,692     $ 4,797  

Schedule of Antidilutive Securities

The following schedule details the number of shares issuable upon the exercise of stock options, warrants and conversion of preferred stock, which have been excluded from the diluted loss per share calculation as the inclusion would be anti-dilutive for the nine months ended September 30, 2018 and 2017:

 

    Three month period
Ended September 30, 		    Nine month period
Ended September 30, 		 
    2018     2017     2018     2017  
Stock options     11,455       11,526       11,455       11,526  
                                 
Common stock issuable upon conversion of preferred stock     28,685       15,078       28,685       15,078  
                                 
Warrants     5,802       5,961       5,802       5,961  
                                 
Total     45,942       32,565       45,942       32,565